Legislation
- Title
- Pharmacists – Administration of Self–Administered Medications and Maintenance Injectable Medications (The Christopher King Access to Treatment Act)
- Sponsored by
- Delegates K. Young, Bagnall, Brooks, Carr, Kipke, Krebs, R. Lewis, Moon, Solomon, Terrasa, Barron, Bhandari, Charles, Chisholm, Cullison, Hill, Johnson, Kelly, Kerr, Morgan, Pena-Melnyk, Pendergrass, Reilly, Rosenberg, Sample-Hughes, and Szeliga
- Status
- In the Senate - First Reading Education, Health, and Environmental Affairs and Finance
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Authorizing a pharmacist who meets certain requirements to administer a maintenance injectable medication to a patient under certain circumstances; requiring the State Board of Pharmacy, by September 1, 2021, and in consultation with the State Board of Physicians and the State Board of Nursing, to adopt regulations establishing standard procedures for approving classes of maintenance injectable medications and requiring pharmacists to complete a certain training program in order to administer a maintenance injectable medication; etc.
Committees
Committee Testimony
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
15-148 )
(
12-101, 12-509 )
(
15-716 )
Last Updated: 9/22/2020 2:00 PM